Keebeck Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Keebeck Wealth Management's PFE Position: Q1 2026 in Review
Keebeck Wealth Management increased its Pfizer (PFE) stake by 50% in Q1 2026, buying an estimated $118K and bringing the position to 13,408 shares worth $377K. The position accounts for 0.04% of the portfolio, ranked #271.
Keebeck Wealth Management first reported a position in PFE in Q4 2019 and has held it in 20 quarters since. The position peaked at $398K in Q3 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Keebeck Wealth Management held 13,408 shares of Pfizer worth $377K as of Q1 2026.
- Keebeck Wealth Management bought 4,445 Pfizer shares in Q1 2026, an estimated $118K.
- Pfizer made up 0.04% of Keebeck Wealth Management's portfolio in Q1 2026, its #271 holding.
- Keebeck Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 20 quarters since.
- Keebeck Wealth Management's Pfizer position peaked at $398K in Q3 2024.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Keebeck Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.